RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.
Read More…
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+49-9-771650
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.46 billion
Profitability
Miscellaneous
Employees9,384
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable
Rhoen Klinikum (ETR:RHK) Frequently Asked Questions
What is Rhoen Klinikum's stock symbol?
Rhoen Klinikum trades on the ETR under the ticker symbol "RHK."
When is Rhoen Klinikum's next earnings date?
What price target have analysts set for RHK?
7 equities research analysts have issued 12-month price targets for Rhoen Klinikum's shares. Their predictions range from €16.50 to €26.20. On average, they expect Rhoen Klinikum's share price to reach €21.96 in the next year. This suggests a possible upside of 12.3% from the stock's current price. View Analyst Price Targets for Rhoen Klinikum.
What is the consensus analysts' recommendation for Rhoen Klinikum?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rhoen Klinikum in the last year. There are currently 4 sell ratings and 3 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rhoen Klinikum.
Has Rhoen Klinikum been receiving favorable news coverage?
Press coverage about RHK stock has been trending very negative on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rhoen Klinikum earned a news impact score of -3.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an impact on the company's share price in the near term. View News Stories for Rhoen Klinikum.
Who are some of Rhoen Klinikum's key competitors?
Some companies that are related to Rhoen Klinikum include Mediclinic International (MDC), Healius (HLS), Spire Healthcare Group (SPI), CareTech (CTH), Virtus Health (VRT), Georgia Healthcare Group (GHG), Pacific Smiles Group (PSQ), Assure (IOM), CENTRIC HEALTH (CHH), Konekt (KKT), Totally (TLY), Brain Resource (BRC), Nobilis Health (HLTH), Venn Life Sciences (VENN) and Wellness and Beauty (WNB).
What other stocks do shareholders of Rhoen Klinikum own?
Who are Rhoen Klinikum's key executives?
Rhoen Klinikum's management team includes the folowing people:
- Mr. Stephan Holzinger, Chairman of Board of Management & CEO
- Prof. Bernd Griewing, Chief Medical Officer & Member of Board of Management
- Dr. Gunther Karl Weiß, COO & Member of Management Board (Age 53)
- Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)
- Julian Schmitt, Head of Investor Relation
What is Rhoen Klinikum's stock price today?
One share of RHK stock can currently be purchased for approximately €19.56.
How big of a company is Rhoen Klinikum?
What is Rhoen Klinikum's official website?
How can I contact Rhoen Klinikum?
Rhoen Klinikum's mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650.
MarketBeat Community Rating for Rhoen Klinikum (ETR RHK)
MarketBeat's community ratings are surveys of what our community members think about Rhoen Klinikum and other stocks. Vote "Outperform" if you believe RHK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHK will underperform the S&P 500 over the long term. You may vote once every thirty days.
